Sall Research Medical Center

Lifitegrast for the Treatment of Dry Eye Disease

Edward J. Holland, Jodi Luchs, Paul Karpecki et al. · Ophthalmology · 2016 · 196 citations · Full text

Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease

Joseph Tauber, Paul Karpecki, Robert Latkany et al. · Ophthalmology · 2015 · 186 citations · Full text

Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy

Rishi P. Singh, Alpern, Jaffe et al. · Clinical ophthalmology · 2012 · 119 citations · Full text

Improvement of Glycemic Control, Triglycerides, and HDL Cholesterol Levels With Muraglitazar, a Dual (α/γ) Peroxisome Proliferator–Activated Receptor Activator, in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

David M. Kendall, Cindy J. Rubin, Pharis Mohideen et al. · Diabetes Care · 2006 · 114 citations

Metformin Monotherapy, Pharmacotherapy, Mg Muraglitazar +18

Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert

James D. Brandt, Kenneth Sall, Harvey Dubiner et al. · Ophthalmology · 2016 · 109 citations · Full text